Search
Anika Therapeutics Inc
ANIKAdd to Watchlist
14.770USD
-0.370-2.44%
Close 05/08, 16:00（ET）Quotes delayed by 15 min
205.14MMarket Cap
LossP/E TTM
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-2.44%
5 Days
-0.54%
1 Month
-2.89%
6 Months
+49.95%
Year to Date
+53.69%
1 Year
+0.20%
TradingKey Stock Score of Anika Therapeutics Inc
Currency: USD Updated: 2026-05-08Key Insights
Anika Therapeutics Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 2 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 17.50.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Anika Therapeutics Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Anika Therapeutics Inc Highlights
StrengthsRisks
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Undervalued
The company’s latest PE is -18.66, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 12.50M shares, decreasing 13.87% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 20.72K shares of this stock.
Analyst Rating
Based on
2
analysts
Strong Buy
Current Rating
17.500
Target Price
+20.27%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Anika Therapeutics Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Anika Therapeutics Inc Info
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Ticker SymbolANIK
CompanyAnika Therapeutics Inc
CEOBlanchard (Cheryl Renee)
Websitehttps://anika.com/
Related Instruments
+2.77%
-1.99%
-0.76%
-3.09%
-2.56%
+3.65%
-2.98%
+1.44%
-2.32%
+1.38%
-4.67%
+1.42%
+2.12%
-3.38%
-2.11%
-2.50%
+11.27%
-2.55%
-5.59%
-2.07%Popular Instruments
92.193
-2.977 (-3.13%)
293.320
+5.880 (+2.05%)
215.200
+3.700 (+1.75%)
4714.280
+29.030 (+0.62%)
480.000
+16.090 (+3.47%)
1562.340
+222.380 (+16.60%)
746.810
+100.180 (+15.49%)
400.800
+2.810 (+0.71%)
80211.980
+108.890 (+0.14%)
428.350
+16.560 (+4.02%)
